HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of therapeutic efficacy of nimesulide and diclofenac in patients with degenerative joint diseases.

Abstract
The efficacy and tolerability profiles of nimesulide and diclofenac were evaluated in 180 patients suffering from various degenerative joint diseases. The clinical evaluations were performed at 0, 2 and 4 weeks. Nimesulide (100 mg) tablets were administered twice daily and diclofenac (50 mg) tablets were administered thrice daily. The principal efficacy parameters were the improvement in pain assessed through verbal scoring. Evaluation of tolerance was also established through similar method. Final judgment on efficacy was made by the physician. In all evaluations nimesulide showed improved efficacy parameters over diclofenac.
AuthorsI Zgradie
JournalJournal of the Indian Medical Association (J Indian Med Assoc) Vol. 97 Issue 4 Pg. 119-23 (Apr 1999) ISSN: 0019-5847 [Print] India
PMID10652894 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Sulfonamides
  • Diclofenac
  • nimesulide
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents, Non-Steroidal (adverse effects, therapeutic use)
  • Diclofenac (adverse effects, therapeutic use)
  • Double-Blind Method
  • Female
  • Humans
  • Lumbosacral Region
  • Male
  • Middle Aged
  • Osteoarthritis (drug therapy)
  • Osteoarthritis, Hip (drug therapy)
  • Osteoarthritis, Knee (drug therapy)
  • Pain (diagnosis, drug therapy)
  • Spinal Diseases (drug therapy)
  • Sulfonamides (adverse effects, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: